Cellebrite DI Ltd. ( CLBT ) NASDAQ Global Select

Cena: 16.42 ( 1.11% )

Aktualizacja 06-26 21:29
NASDAQ Global Select
Branża: Software - Infrastructure
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Technologia
Branża: Software - Infrastructure
Zatrudnienie: 1 008
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 32%
Ilość akcji: 197 368 000
Debiut giełdowy: 2020-11-06
WWW: https://www.cellebrite.com
CEO: Mr. Yossi Carmil
Adres: 94 Shlomo Shmelzer Road
Siedziba: 4970602 Petah Tikva
ISIN: IL0011794802
Opis firmy:

Cellebrite Di Ltd. opracowuje rozwiązania do badań prawnie usankcjonowanych. Platforma DI pozwala użytkownikom zbierać, przeglądać, analizować i zarządzać danymi cyfrowymi w całym cyklu życia śledczego w odniesieniu do legalnie sankcjonowanych dochodzeń, a rozwiązania są wykorzystywane w różnych sprawach, w tym wykorzystywanie dzieci, zabójstwo, antyterror, kontrola graniczna, przestępstwa seksualne, handel ludźmi, bezpieczeństwo korporacyjne, kradzieży własności intelektualnej i postępowania w zakresie obywatelskich. Uniwersalne rozwiązanie urządzenia do ekstrakcji kryminalistycznej rozwiązuje problemy w dostępie do informacji cyfrowych, w tym skomplikowane zamki urządzeń, bariery szyfrowania, usuniętą i nieznaną zawartość oraz inne przeszkody, które mogą zapobiec wychodzeniu na światło krytycznych dowodów. Oferuje również rozwiązanie Poszukiwacza, które zapewnia możliwość analizy materiału wideo; Osint Analize, rozwiązanie głębokiego nurkowania w czasie rzeczywistym używane do analizy informacji open source, takich jak Surface Web, Deep Web i Dark Web; oraz Crypto Tracer, który analizuje transakcje blockchain wraz z powiązanymi danymi z obszernej listy źródeł w celu identyfikacji i kategoryzacji portfeli oraz transakcji. Firma obsługuje agencje federalne, stanowe i lokalne, a także przedsiębiorstwa i usługodawcy. Działa w Stanach Zjednoczonych, Niemczech, Singapurze, Australii, Brazylii, Wielkiej Brytanii, Francji, Kanadzie, Japonii i Indiach. Firma została zarejestrowana w 1999 r. I ma siedzibę w Petah Tikva w Izraelu. Cellebrite Mobile Synchronizacja Ltd. działa jako spółka zależna Sun Corporation.

Wskaźniki finansowe
Kapitalizacja (USD) 3 932 097 400
Aktywa: 629 246 000
Cena: 16.42
Wskaźnik Altman Z-Score: 8.4
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: -17.9
Ilość akcji w obrocie: 32%
Średni wolumen: 1 402 071
Ilość akcji 239 470 000
Wskaźniki finansowe
Przychody TTM 385 167 000
Zobowiązania: 330 930 000
Przedział 52 tyg.: 11.47 - 26.3
Piotroski F-Score: 4
Umiarkowany (średnia jakość finansowa)
EPS: -0.9
P/E branży: 27.8
Beta: 1.499
Raport okresowy: 2025-08-14
WWW: https://www.cellebrite.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Dana Gerner Chief Financial Officer 649 000 1967
Mr. Ronnen Armon Chief Products & Technologies Officer 516 000 1963
Mr. Leeor Ben-Peretz Chief Strategy Officer 470 000 1976
Mr. Yossi Carmil Founder, Chief Executive Officer & Director 1 138 000 1968
Andrew Kramer Vice President of Investor Relations 0 0
Ms. Zohar Tadmor-Eilat Chief People Officer 0 1971
Mr. Marcus Jewell Global Chief Revenue Officer 0 1973
Ms. Ayala Berler Shapira General Counsel & Chief Compliance Officer 0 1971
Mr. Thomas E. Hogan Executive Chairman 0 1959
Mr. David Nicholas Gee Chief Marketing Officer 0 1967
Wiadomości dla Cellebrite DI Ltd.
Tytuł Treść Źródło Aktualizacja Link
Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Tomer Zilberman - Bank of America Jeff Rhee - Craig-Hallum Mike Cikos - Needham Jonathan Ho - William Blair Shaul Eyal - TD Cowen Eric Martinuzzi - Lake Street Operator Welcome to the Cellebrite First Quarter 2025 Financial Results Conference Call. seekingalpha.com 2025-05-14 15:22:42 Czytaj oryginał (ang.)
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. zacks.com 2025-05-14 13:16:02 Czytaj oryginał (ang.)
Cellebrite Announces First-Quarter 2025 Results First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue globenewswire.com 2025-05-14 11:00:00 Czytaj oryginał (ang.)
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform globenewswire.com 2025-05-06 12:30:00 Czytaj oryginał (ang.)
Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025 TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. globenewswire.com 2025-04-10 12:30:00 Czytaj oryginał (ang.)
10 Winners Awarded “Justies” at Cellebrite's First-Ever Digital Justice Awards The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees globenewswire.com 2025-04-01 12:30:00 Czytaj oryginał (ang.)
Cellebrite Files its 2024 Annual Report on Form 20-F TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”). globenewswire.com 2025-03-18 11:00:00 Czytaj oryginał (ang.)
SMGZY or CLBT: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-02-28 14:46:36 Czytaj oryginał (ang.)
After Plunging -17.61% in 4 Weeks, Here's Why the Trend Might Reverse for Cellebrite DI Ltd. (CLBT) Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. zacks.com 2025-02-25 12:35:26 Czytaj oryginał (ang.)
Is This Stock a Next-Gen Digital Forensics Leader? In this video, Anand Chokkavelu, Travis Hoium, and Lou Whiteman discuss Cellebrite (CLBT -5.53%), a key player in digital forensics for law enforcement. They provide ratings and insights on its growth potential, management, and financials, helping you decide if this stock is a worthy investment. fool.com 2025-02-17 21:00:00 Czytaj oryginał (ang.)
Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript Cellebrite DI Ltd. (NASDAQ:CLBT ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Shaul Eyal - TD Cowen Bhavin Shah - Deutsche Bank Eric Martinuzzi - Lake Street Charlotte Bedick - JPMorgan Jeff Rhee - Craig-Hallum Mike Cikos - Needham Tomer Zilberman - Bank of America Louie DiPalma - William Blair Operator Welcome to the Cellebrite Fourth Quarter and Full Year 2024 Financial Results Conference Call. seekingalpha.com 2025-02-13 21:14:26 Czytaj oryginał (ang.)
Cellebrite DI Ltd. (CLBT) Q4 Earnings Meet Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. zacks.com 2025-02-13 11:21:23 Czytaj oryginał (ang.)
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to 21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024. globenewswire.com 2025-02-13 09:00:00 Czytaj oryginał (ang.)
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status Cellebrite's SaaS solution accelerates, expands and simplifies access to secure data collection and analysis Cellebrite's SaaS solution accelerates, expands and simplifies access to secure data collection and analysis globenewswire.com 2025-02-12 10:30:00 Czytaj oryginał (ang.)
Cellebrite to Report Q4 Earnings: Here's What You Should Know The surge in subscription filters is likely to have benefited CLBT's top line in the fourth quarter of 2024. zacks.com 2025-02-11 14:50:18 Czytaj oryginał (ang.)
Value of AI, Cloud Solutions Reign in Cellebrite's 2025 Annual Industry Trends Survey TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the release of its sixth annual 2025 Industry Trends Survey. globenewswire.com 2025-02-11 10:30:00 Czytaj oryginał (ang.)
Cellebrite's Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the general availability of Generative Artificial Intelligence (GenAI) capabilities within Guardian, the Company's SaaS-based evidence management solution. globenewswire.com 2025-02-06 10:30:00 Czytaj oryginał (ang.)
Cellebrite: Country-Wide US Adoption In The Public Sector Is Remarkable Cellebrite DI LTD (CLBT) offers unique digital investigative solutions to governmental agencies, showing strong market position and 172% stock growth in the past year. CLBT's ambitious financial targets include 24% CAGR in ARR and 20% CAGR in total revenues by 2028, with significant margin improvements since 2022. Despite a potential short-term sell-off, CLBT's low short interest and international customer base, especially in high-growth markets, mitigate long-term risks. seekingalpha.com 2025-02-04 07:58:32 Czytaj oryginał (ang.)
Cellebrite DI: Attractive Company In Connection With AI And Digital Investigation Cellebrite DI is a top digital forensics play with high barriers to entry, double-digit growth, positive FCF, and a strong balance sheet. The company serves major police forces and Fortune 100 companies, with significant room for growth and high switching costs due to security clearances and data. Cellebrite's competitive edge includes user-friendly digital investigation tools, advanced phone encryption cracking, and AI capabilities, making it essential for law enforcement. seekingalpha.com 2025-02-04 06:08:07 Czytaj oryginał (ang.)
Cellebrite Announces Participation in the UBS Global Technology and AI Conference TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG} Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming UBS Global Technology and AI Conference. Relevant details include: globenewswire.com 2024-11-25 10:30:00 Czytaj oryginał (ang.)
Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape Cellebrite Endpoint Inspector Solutions are now generally available within RelativityOne Cellebrite Endpoint Inspector Solutions are now generally available within RelativityOne globenewswire.com 2024-11-20 10:30:00 Czytaj oryginał (ang.)
NU or CLBT: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Technology Services sector might want to consider either Nu Holdings Ltd. (NU) or Cellebrite DI Ltd. zacks.com 2024-11-11 14:45:44 Czytaj oryginał (ang.)
Cellebrite DI: Long-Term Growth Looks Positive, But Valuation Increased I previously rated Cellebrite DI a 'strong buy' due to its growth potential and attractive valuation. Since my recommendation, Cellebrite has outperformed, with the stock rising 160% compared to the S&P 500's 33% increase. Cellebrite has positive developments from its Q3 2024 earnings report. seekingalpha.com 2024-11-11 14:43:09 Czytaj oryginał (ang.)
Cellebrite: There Are Potential Risks That Could Damper Growth I maintain a neutral rating on Cellebrite due to its premium valuation and risks from CEO transition and potential federal budget cuts. Despite solid growth, including a 27% revenue increase and expanding margins, uncertainties around leadership and federal funding impact my outlook. Strong adoption of Inseyets, Guardian, and Pathfinder products, with notable ARR growth, suggests a long growth runway ahead. seekingalpha.com 2024-11-08 11:22:50 Czytaj oryginał (ang.)
Cellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call Transcript Cellebrite DI Ltd. (NASDAQ:CLBT ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Andrew Kramer - Investor Relations Yossi Carmil - CEO Dana Gerner - CFO Thomas Hogan - Executive Chairman Conference Call Participants Shaul Eyal - TD Cowen Michael Cikos - Needham Jeffrey Van Rhee - Craig-Hallum Brian Essex - JP Morgan Jonathan Ho - William Blair Tomer Zilberman - Bank of America Max Michaels - Lake Street Capital Operator Welcome to the Cellebrite Third Quarter 2024 Financial Results Conference Call. seekingalpha.com 2024-11-06 17:44:43 Czytaj oryginał (ang.)
Cellebrite DI Ltd. (CLBT) Tops Q3 Earnings and Revenue Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. zacks.com 2024-11-06 11:25:48 Czytaj oryginał (ang.)
CORRECTION: Cellebrite Announces Third-Quarter 2024 Results Third- q uarter 2024 r evenue of $106.9 million exceeds $100 million quarterly revenue milestone  for the first time in Company history globenewswire.com 2024-11-06 10:26:00 Czytaj oryginał (ang.)
Yossi Carmil to Step Down as CEO After Nearly 20 Years TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. globenewswire.com 2024-11-06 10:20:00 Czytaj oryginał (ang.)
What Makes Cellebrite DI Ltd. (CLBT) a New Strong Buy Stock Cellebrite DI Ltd. (CLBT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com 2024-10-14 17:01:25 Czytaj oryginał (ang.)
Cellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024 TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2024 financial results before market open on Wednesday, November 6, 2024. globenewswire.com 2024-10-10 12:30:00 Czytaj oryginał (ang.)
Cellebrite DI Ltd. (CLBT) Hit a 52 Week High, Can the Run Continue? Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future? zacks.com 2024-10-08 14:20:29 Czytaj oryginał (ang.)
Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year? Here is how Cellebrite DI Ltd. (CLBT) and Nexxen International Ltd. zacks.com 2024-10-04 14:41:12 Czytaj oryginał (ang.)
Cellebrite Patents its Remote Mobile Collection Capabilities for Businesses Remote Mobile Collection enables faster device access and analysis, saving corporate investigators time and money Remote Mobile Collection enables faster device access and analysis, saving corporate investigators time and money globenewswire.com 2024-09-24 12:30:00 Czytaj oryginał (ang.)
Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the results of the completed redemption (the “Redemption”) of its Warrants (as defined below) to purchase ordinary shares of the Company (the “Ordinary Shares”). globenewswire.com 2024-09-18 20:15:00 Czytaj oryginał (ang.)
Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS) Pathfinder's capabilities are now available via the cloud,  giving law enforcement new deployment options to accelerate justice globenewswire.com 2024-09-16 12:30:00 Czytaj oryginał (ang.)
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the “Redemption Fair Market Value” in connection with its previously announced redemption of its warrants (the “Warrants”) to purchase ordinary shares of the Company (the “Ordinary Shares”). globenewswire.com 2024-08-30 12:00:00 Czytaj oryginał (ang.)
Cellebrite: Rating Downgrade As Valuation Has Caught Up Cellebrite's 2Q24 results exceeded expectations with solid revenue growth and profit metrics. Progress in key metrics and initiatives indicate potential for >20% growth in the future. CLBT's Valuation has caught up, making the upside less attractive despite a positive fundamental outlook. seekingalpha.com 2024-08-27 00:55:50 Czytaj oryginał (ang.)
Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. zacks.com 2024-08-19 17:21:09 Czytaj oryginał (ang.)
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year? Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year. zacks.com 2024-08-16 14:46:11 Czytaj oryginał (ang.)